Hair Restoration: Frequently Asked Questions

Hair restoration spans surgical, pharmaceutical, and device-based interventions governed by federal and state-level oversight, with outcomes shaped by patient biology, technique selection, and provider qualifications. These questions address the full scope of the field — from how candidacy is determined to what the regulatory environment looks like — giving readers a structured foundation before engaging any clinical process. The answers reflect established clinical frameworks, named regulatory bodies, and published classification systems rather than advisory recommendations.

What triggers a formal review or action?

Formal clinical and regulatory review in hair restoration is triggered by specific clinical findings, device classifications, and adverse event reports. The U.S. Food and Drug Administration (FDA) classifies hair restoration devices under 21 CFR Part 878, which governs general and plastic surgery devices. Low-level laser therapy (LLLT) devices cleared through the 510(k) premarket notification pathway, for example, require documented substantial equivalence to a predicate device before entering the market.

On the clinical side, a formal consultation is triggered when standardized hair loss scales — such as the Norwood Scale for men or the Ludwig Scale for women — indicate progression beyond early-stage loss, or when diffuse thinning suggests an underlying systemic cause requiring differential diagnosis before any procedure. Adverse event reporting to MedWatch, the FDA's voluntary and mandatory reporting system, triggers agency review when device-related injuries or complications are documented.

How do qualified professionals approach this?

Board-certified physicians who perform hair restoration typically hold credentials from the American Board of Hair Restoration Surgery (ABHRS) or the American Board of Plastic Surgery, among others. The ABHRS administers a written and oral examination covering surgical anatomy, medical hair loss management, and procedural technique.

Qualified professionals begin with a detailed scalp assessment, review of systemic health history, and dermoscopic evaluation of follicular density. They assess donor area supply — typically the occipital scalp — against the projected recipient demand using graft density calculations. The approach to any individual patient is structured around loss classification, donor reserve, age, and the likelihood of future progression. Professionals reference the safety context and risk boundaries for hair restoration established by clinical consensus when setting expectations for outcomes and complications.

What should someone know before engaging?

Before engaging any hair restoration provider, patients benefit from understanding 4 foundational facts:

  1. Hair loss progression continues after any procedure. A transplant moves existing follicles but does not halt native hair loss. Concurrent medical therapy — commonly finasteride or minoxidil — is often recommended to stabilize non-transplanted hair.
  2. Donor supply is finite. Each individual has a limited number of transplantable follicular units; overharvesting the donor zone creates permanent depletion.
  3. Results take 12 to 18 months to fully manifest. Transplanted grafts shed within weeks (a process called shock loss), followed by regrowth that matures over more than a year.
  4. Regulatory protection varies by jurisdiction. In the United States, the FDA oversees devices and drugs used in hair restoration, but surgical technique regulation falls to individual state medical boards.

The hair restoration consultation: what to expect covers the specific evaluation steps in detail.

What does this actually cover?

Hair restoration encompasses a spectrum of interventions that differ in mechanism, invasiveness, and evidence base. Surgical options include Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE), and robotic-assisted systems such as the ARTAS platform, which received FDA 510(k) clearance. Non-surgical options include FDA-cleared LLLT devices, platelet-rich plasma (PRP) therapy, and scalp micropigmentation, which is a cosmetic tattooing technique rather than a medical procedure.

Pharmacological options include FDA-approved minoxidil (topical and oral formulations) and finasteride (approved for male androgenetic alopecia), as well as dutasteride, which carries FDA approval for benign prostatic hyperplasia but is used off-label for hair loss. The types of hair restoration procedures page maps the full landscape with procedural distinctions.

What are the most common issues encountered?

The most frequently encountered clinical issues in hair restoration fall into 3 categories:

Medical tourism introduces additional risk vectors. Clinics operating outside U.S. jurisdiction are not subject to FDA oversight or state medical board standards. The medical tourism hair transplant risks page details the specific documented risk categories.

How does classification work in practice?

Hair loss classification is the primary tool for determining candidacy and procedure planning. The Norwood-Hamilton Scale classifies male androgenetic alopecia across 7 stages (I through VII), with Stage VII representing the most extensive loss — a narrow horseshoe-shaped band of hair remaining at the sides and back of the scalp. The Ludwig Scale classifies female pattern hair loss across 3 grades based on crown thinning width and vertex involvement.

These scales are used in combination with trichoscopic measurements — follicular density expressed in follicular units per cm² — to calculate realistic graft requirements. A patient at Norwood Stage V, for example, may require 2,500 to 3,500 grafts to achieve meaningful coverage, a figure that must be reconciled against measured donor density. The androgenetic alopecia explained resource elaborates on the biological mechanisms underlying each classification stage.

What is typically involved in the process?

Hair restoration procedures follow a structured sequence regardless of technique:

  1. Consultation and candidacy assessment — Medical history, scalp examination, and hair loss classification.
  2. Pre-procedure preparation — Blood work in some cases, cessation of specific medications (aspirin, NSAIDs) to reduce bleeding risk, and scalp preparation protocols. The hair transplant pre-procedure preparation page covers specifics.
  3. Donor harvesting — Either strip excision (FUT) or individual follicle extraction (FUE) from the occipital and parietal donor zones.
  4. Graft processing — Dissection of follicular units under stereo-microscopy; grafts are stored in a chilled saline or holding solution.
  5. Recipient site creation and implantation — Sites are created at defined angles and densities; grafts are placed to replicate natural hair direction.
  6. Post-operative care — Detailed care protocols govern the first 10 days; full recovery and final assessment occur at the 12–18 month mark. See hair transplant recovery timeline for the phased breakdown.

What are the most common misconceptions?

Several persistent misconceptions shape patient expectations in ways that lead to dissatisfaction or poor decision-making:

Misconception 1 — A single procedure restores all lost hair. Transplantation redistributes existing hair; it cannot create new follicles or exceed the donor supply. Patients with extensive loss (Norwood VI–VII) may achieve density coverage only over a limited area.

Misconception 2 — Transplanted hair is permanent and immune to loss. Follicles harvested from the occipital donor zone are generally resistant to dihydrotestosterone (DHT)-mediated miniaturization, which is why they are selected. However, "donor dominance" — the principle that transplanted follicles retain their original characteristics — is not absolute under all conditions, particularly in patients with diffuse unpatterned alopecia.

Misconception 3 — Non-surgical options are equivalent to surgical ones. Minoxidil and LLLT can slow progression and modestly increase density in responsive patients, but published clinical trials do not support equivalence with surgical redistribution for patients with established pattern baldness.

Misconception 4 — All hair restoration clinics operate under equivalent standards. Accreditation status, physician credentials, and facility inspection requirements vary significantly across states. The board certifications for hair restoration surgeons and hair restoration clinic accreditation pages detail the specific credentialing benchmarks.

The Hair Restoration Authority home provides a navigational reference to the full body of clinical, procedural, and regulatory content covered across this resource.

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)